Aker Biomarine AS Market Cap ($1.13 Billion)
Market Cap & Net Worth: Aker Biomarine AS (AKBM)
Aker Biomarine AS market cap. Aker Biomarine AS (OL:AKBM) has a market capitalization of $1.13 Billion (Nkr10.70 Billion) as of November 1, 2026. Listed on the OL stock exchange, this Norway-based company holds position #8090 globally and #64 in its home market, demonstrating a -6.15% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Aker Biomarine AS's stock price Nkr122.00 by its total outstanding shares 87703399 (87.70 Million). Also see AKBM operating cash flow for how efficiently the company converts equity into cash flow.
Aker Biomarine AS Market Cap History (2020–2026)
Aker Biomarine AS market cap history from 2020 to 2026. Data shows growth from $603.16 Million to $1.13 Billion (12.57% CAGR). Check AKBM stock price for real-time trading data and today's change.
Aker Biomarine AS Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Aker Biomarine AS's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Explore Aker Biomarine AS equity growth rate to track how rapidly the company is growing its equity base year over year.
Latest Price to Sales (P/S) Ratio
3.11x
Aker Biomarine AS's market cap is 3.11 times its annual revenue
Latest Price to Earnings (P/E) Ratio
3.40x
Aker Biomarine AS's market cap is 3.40 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2020 | $603.16 Million | $288.59 Million | -$5.46 Million | 2.09x | N/A |
| 2021 | $278.74 Million | $262.06 Million | -$8.01 Million | 1.06x | N/A |
| 2022 | $195.32 Million | $277.20 Million | $10.00 Million | 0.70x | 19.53x |
| 2023 | $236.13 Million | $335.30 Million | -$8.90 Million | 0.70x | N/A |
| 2024 | $619.26 Million | $199.00 Million | $182.40 Million | 3.11x | 3.40x |
Competitor Companies of AKBM by Market Capitalization
Companies near Aker Biomarine AS in the global market cap rankings as of November 1, 2026. Also see Aker Biomarine AS total assets for a full breakdown of the balance sheet.
Key companies related to Aker Biomarine AS by market ranking:
- Nestlé S.A (F:NESM): Ranked #88 globally with a market cap of $224.33 Billion USD ( €191.89 Billion EUR).
- Nestle S.A. (SW:NESN): Ranked #102 globally with a market cap of $199.45 Billion USD ( CHF157.76 Billion CHF).
- Danone SA (PA:BN): Ranked #542 globally with a market cap of $49.33 Billion USD ( €42.19 Billion EUR).
- Danone SA (F:BSND): Ranked #674 globally with a market cap of $39.61 Billion USD ( €33.88 Billion EUR).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #88 | Nestlé S.A | F:NESM | $224.33 Billion | €91.60 |
| #102 | Nestle S.A. | SW:NESN | $199.45 Billion | CHF84.70 |
| #542 | Danone SA | PA:BN | $49.33 Billion | €65.52 |
| #674 | Danone SA | F:BSND | $39.61 Billion | €12.40 |
Market Capitalization of Aker Biomarine AS (2020–2026)
Market capitalization of Aker Biomarine AS from 2020 to today. Between 2020 and today, Aker Biomarine AS's market cap moved from $603.16 Million to $ 1.13 Billion, with a yearly change of 12.57%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | Nkr1.13 Billion | +23.61% |
| 2025 | Nkr910.89 Million | +47.09% |
| 2024 | Nkr619.26 Million | +162.25% |
| 2023 | Nkr236.13 Million | +20.89% |
| 2022 | Nkr195.32 Million | -29.93% |
| 2021 | Nkr278.74 Million | -53.79% |
| 2020 | Nkr603.16 Million | -- |
End of Day Market Cap According to Different Sources
On Oct 31st, 2026 the market cap of Aker Biomarine AS was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $1.13 Billion USD |
| MoneyControl | $1.13 Billion USD |
| MarketWatch | $1.13 Billion USD |
| marketcap.company | $1.13 Billion USD |
| Reuters | $1.13 Billion USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Aker Biomarine AS
Aker BioMarine ASA, a biotech innovator, develops and supplies krill-derived products for consumer health and wellness worldwide. It operates through three segments: Human Health Ingredients (HHI), Consumer Health Products, and Emerging Business. The Human Health Ingredients segment sells B2B krill oil supplements for humans under the Superba Krill brand; supplements for brain health under the LY… Read more